PregnanTech News
4 articles
Confronting the Preterm Birth Crisis: A New Hope on the Horizon
PregnanTech, a medical technology company, has introduced LIONESS™, a non-surgical device designed to reduce preterm birth (PTB) rates. The device, a silicone ring placed around the cervix, has shown promising results in clinical trials, with a high rate of term births and no significant side effects. The company plans to conduct a pivotal study in the United States in 2025 to further prove the devices efficacy and support the FDA approval process. LIONESS™ offers a new hope for families at risk of PTB, potentially saving tens of thousands of babies annually.
Product StageFDA approved/pending approval
Trendlines' PregnanTech developing Lioness device to prevent preterm birth - BioTuesdays
PregnanTech, a medical technology company, is conducting a clinical safety study with its Lioness device to prevent preterm birth. The CEO, Dr. David Shashar, believes that Lioness has the potential to reduce the rate of preterm birth and improve outcomes for neonates. The device is a disposable silicone ring placed in the vagina and secured around the uterine cervix to keep it elongated and closed. PregnanTech plans to conduct a larger proof-of-concept study in 2021 and is raising $1.1 million for its trials. The company also has plans for a pivotal study in 2022-2023 to seek regulatory approval and begin sales in the U.S. and Europe in 2024. PregnanTechs target market includes obstetric and gynecology clinics and obstetric hospital departments.
InvestmentExpand
LIONESS Device to Help Prevent Preterm Birth
PregnanTech, an Israeli company, has developed an implantable device called LIONESS that aims to prevent premature birth. The device reduces the load on the cervix, delays the biomechanical cascade, and prevents spontaneous birth. It is currently being tested in a clinical safety trial and is planned to be trialed at Kings College Hospital in London next year. The CEO of PregnanTech highlights the importance of each additional week in the womb for fetal development and the lack of successful solutions for preventing premature birth. The company sees a large target market and potential breakthrough in the medical field.
Customers
https://www.jpost.com/health-science/novel-device-that-prevents-preterm-birth-developed-in-israel-637220
Israeli company PregnanTech has developed a medical device called Lioness to prevent premature birth. The device, a silicon ring placed around the uterine cervix, aims to delay preterm birth by keeping the cervix elongated and closed. PregnanTech is conducting a clinical trial to evaluate the safety of Lioness and plans to conduct a second trial with pregnant women at risk for preterm birth. The company estimates the market potential for Lioness to be over $2 billion annually in developed countries alone. PregnanTech is open to investment to support the product.
CustomersInvestment
